SanaHeal

SanaHeal

Innovative bioadhesive solutions for rapid, robust, and blood-resistant tissue repair in clinical scenarios.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
*

N/A

-
Total Funding000k
Notes (0)
More about SanaHeal
Made with AI
Edit

SanaHeal specializes in developing advanced bioadhesive technologies designed to address the challenges of rapid and effective tissue repair in various clinical scenarios. The company serves healthcare providers and medical institutions by offering bioadhesive patches and pastes that ensure rapid, robust, and blood-resistant sealing of tissue injuries. Operating in the medical devices market, SanaHeal's business model revolves around the development, production, and licensing of its proprietary bioadhesive technologies. The company generates revenue through the sale of its bioadhesive products and licensing agreements with medical institutions and healthcare providers. SanaHeal's products are engineered based on materials with a history of use in FDA-approved medical devices, ensuring high biosafety and tunable biodegradability. The company's innovations have been highlighted in prestigious publications and media outlets, reflecting its commitment to advancing medical technology.

Keywords: bioadhesive, tissue repair, medical devices, healthcare, clinical scenarios, biosafety, biodegradability, rapid sealing, blood-resistant, innovation.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads